China Neonatal Genome Project to Sequence 100,000 Newborns and Improve Genetic Disease Diagnosis and Counseling

What this Trial Is About

The China Neonatal Genomes Project aims to carry out genetic testing on 100,000 newborns over five years to build a comprehensive neonatal genome database for Chinese infants. This project focuses on early identification and diagnosis of hereditary diseases like primary immune deficiency, genetic metabolic disorders, and multiple malformation syndromes. By improving diagnosis and prevention, the study hopes to support precise treatment and better quality of life for newborns in China. Participants include infants and their parents recruited from Neonatal Intensive Care Units of member hospitals. The infants, who are less than 28 days old, will receive genomic sequencing without randomization. The sequencing report will include findings on pathogenic variants linked to childhood-onset diseases. Results disclosure sessions will review family history, standard newborn screening, medical history, physical exams, and genomic sequencing findings. This project also aims to establish genetic testing standards and enhance genetic counseling training. Families involved will receive consultations from study physicians and genetic counselors who will use medical and family history alongside newborn screening data. The genetic testing process lasts up to three months from birth. Researchers will measure the number of gene sequences added to the neonatal gene bank and the gene mutation rate. The study supports long-term improvement in genetic disease diagnosis and intervention for newborns, with ongoing monitoring of genetic data and counseling support.

The China Neonatal Genomes Project